Results 21 to 30 of about 383 (191)
Attacking the public health crisis of hepatocellular carcinoma at its roots
Abstract As the third most common cause of cancer‐related death worldwide with significant mortality rates in the United States, hepatocellular carcinoma has strong association with cirrhosis and chronic hepatitis B virus (HBV) with a growing at‐risk population from the rise in chronic liver disease from alcohol use and nonalcoholic fatty liver disease.
Hannah M. Lee +3 more
wiley +1 more source
Objectives: To assess the completeness of ACIR data for south‐eastern Sydney children at 12 to
Susan J. Botham +3 more
doaj +1 more source
Objective: Vaccinations in Australia are reportable to the Australian Immunisation Register (AIR). Following major immunisation policy initiatives, the New South Wales (NSW) Public Health Network undertook an audit to estimate true immunisation coverage ...
Charlee Law +12 more
doaj +1 more source
Background: The identification of determinants of vaccination coverage and delays is important because these predictors identify subsets of the population that can be targeted with public health interventions.
D Gibson, PhD +4 more
doaj +1 more source
Determinants of immunisation in children with sickle cell disease in Libreville
Background: Infectious diseases are frequent and sometimes deadly in sickle cell disease (SCD) patients. Some of these infectious diseases could be avoided through immunisation, but an immunisation schedule for children with SCD is not available in Gabon.
Edgard B. Ngoungou +5 more
doaj +1 more source
Summary AIMS OF THE STUDY: Surveillance of pertussis at a national level is important to collect information on the epidemiology of the disease and to design optimal immunisation strategies.
Jana Zumstein, Ulrich Heininger
doaj +1 more source
Respiratory syncytial virus seasonality and its implications on prevention strategies
With maternal and infant vaccines against respiratory syncytial virus (RSV) in development, it is timely to consider how the deployment of these vaccines might vary according to local RSV disease seasonality.
Sophie Janet +2 more
doaj +1 more source
Radiotherapy‐treated tumor membranes are integrated with Mn‐MOF nanoadjuvants to generate Mn@RM, a lymph node‐draining nanovaccine that delivers radiotherapy‐remodeled antigenic components. Mn@RM enhances dendritic cell activation, amplifies T cell‐mediated antitumor immunity, and synergizes with radiotherapy and PD‐1 blockade for combination cancer ...
Yiyu Wang +8 more
wiley +1 more source
A fully synthetic four‐component vaccine has been developed combining Tn antigen, vizantin (Mincle agonist), rhamnose (antibody recruitment), and mannose (CD206 targeting). By synergistically activating Mincle, FcγR, and CD206 pathways, it elicits strong IgG switching and cytotoxic T‐cells, significantly inhibiting tumors in mice.
Wenbo Ming +9 more
wiley +1 more source
Introduction Immunisation coverage in low- and middle-income countries continues to face challenges due to persistent gaps in vaccination schedule knowledge among caregivers and health workers.
Priyanka Das +6 more
doaj +1 more source

